DMII — DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 71 SEC-registered investment managers reported holding DMII (DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00) in their latest 13F filings, with a combined reported value of $492.18M across 48.92M shares. That is +6.7% by share count (+3.00M shares) versus the previous quarter, while reported value moved +7.7%. Ownership is concentrated: the five largest holders account for 26.1% of reported value and the top ten for 45.1%.
Compared with the prior quarter, 7 opened new positions, 17 added to existing stakes, 12 trimmed, 6 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00 (DMII) include Karpus Management, Inc., Magnetar Financial LLC, MMCAP International Inc. SPC, ranked by reported 13F value among the 80 institutional holders on this page.
DMII is classified in the Financials sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 35 | 22.82M | $232.43M | +1.5% |
| Q2 2026 | 71 | 48.92M | $492.18M | +6.7% |
| Q1 2026 | 70 | 47.29M | $471.70M | +4.9% |
| Q4 2025 | 53 | 37.22M | $367.64M | — |
Over the 4 quarters shown, institutional share counts decreased 39% in aggregate (Q4 2025 → Q3 2026); the largest single-quarter swing was Q2 2026 (+6.7%).
Top Institutional Holders (Q3 2026) — 25 funds
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
Q4 2025 — 25 funds
New Positions (Q2 2026)
- TIG Advisors, LLC 500.00K sh · $5.03M
- CANTOR FITZGERALD, L. P. 363.10K sh · $3.65M
- SkyView Investment Advisors, LLC 250.00K sh · $2.52M
- Kepos Capital LP 210.00K sh · $2.11M
- Arax Advisory Partners 65.99K sh · $663.86K
- GEODE CAPITAL MANAGEMENT, LLC 39.65K sh · $398.87K
- Tuttle Capital Management, LLC 10.77K sh · $108.34K
Fully Exited (vs previous quarter)
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND sold 2.00M sh · $19.96M
- Sculptor Capital LP sold 500.00K sh · $4.99M
- Parallax Volatility Advisers, L.P. sold 133.65K sh · $1.34M
- CSS LLC/IL sold 110.04K sh · $1.10M
- DELTEC ASSET MANAGEMENT LLC sold 50.00K sh · $498.50K
- MIZUHO SECURITIES USA LLC sold 18.60K sh · $184.14K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 |
|---|---|---|---|---|
| Karpus Management, Inc. | 3.30M | 2.79M | 2.60M | 1.14M |
| Magnetar Financial LLC | 2.70M | 2.70M | 2.70M | 2.70M |
| MMCAP International Inc. SPC | 2.70M | 2.70M | 2.70M | — |
| Hudson Bay Capital Management LP | 1.97M | 1.97M | 1.97M | 1.97M |
| WOLVERINE ASSET MANAGEMENT LLC | 1.84M | 1.86M | 1.80M | 1.06M |
| First Trust Capital Management L.P. | 1.30M | 1.07M | 1.07M | 2.07M |
| Crossingbridge Advisors, LLC | 1.10M | 1.10M | 350.00K | — |
| OMERS ADMINISTRATION Corp | 1.00M | 1.00M | 1.00M | 1.00M |
| PICTON MAHONEY ASSET MANAGEMENT | 888.00K | 888.00K | 875.00K | 875.00K |
| Westchester Capital Management, LLC | 771.80K | 621.80K | 500.01K | 500.00K |
| Mercuria Capital Strategies, LLC | 750.00K | 750.00K | 750.00K | — |
| Context Capital Management, LLC | 749.61K | 750.00K | 750.00K | 750.00K |
| HighTower Advisors, LLC | 546.61K | 566.61K | 714.61K | 789.61K |
| BlueCrest Capital Management Ltd | 500.00K | 500.00K | 500.00K | — |
| Wealthspring Capital LLC | 399.15K | 400.44K | 402.67K | 408.95K |
| BNP PARIBAS FINANCIAL MARKETS | 394.95K | 394.95K | 394.95K | 348.60K |
| Mint Tower Capital Management B.V. | 250.00K | 250.00K | 250.00K | 250.00K |
| Kepos Capital LP | 210.00K | 210.00K | — | — |
| Verition Fund Management LLC | 202.84K | 202.84K | 202.84K | 200.00K |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 179.50K | 179.50K | 179.50K | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold DMII?
As of 2026-Q2, 71 institutional funds reported holding DMII (DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00) in SEC 13F filings, with a combined reported value of $492.18M.
How many shares of DMII do institutions own?
13F filers reported 48.92M shares of DMII, worth $492.18M in aggregate at the end of 2026-Q2.
Is institutional ownership of DMII rising or falling?
Share counts moved +6.7% versus the prior quarter — accumulation.
Who are the top institutional holders of DMII?
The largest 13F holders are Karpus Management, Inc., Magnetar Financial LLC, MMCAP International Inc. SPC, GLAZER CAPITAL, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00?
The major shareholders of DRUGS MADE IN AMERICA ACQ CRP II; TNT ACQ DT: 9/25/2027; CASH: $10.00 (DMII) by reported 13F value are Karpus Management, Inc., Magnetar Financial LLC, MMCAP International Inc. SPC, GLAZER CAPITAL, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, among 80 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.